| Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex JJ Kwon, B Hajian, Y Bian, LC Young, AJ Amor, JR Fuller, CV Fraley, ... Nature 609 (7926), 408-415, 2022 | 38 | 2022 |
| An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models CE Canal, DE Felsing, Y Liu, W Zhu, JAT Wood, CK Perry, R Vemula, ... ACS chemical neuroscience 6 (7), 1259-1270, 2015 | 38 | 2015 |
| Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modeling CK Perry, AB Casey, DE Felsing, R Vemula, M Zaka, NB Herrington, ... Bioorganic & Medicinal Chemistry 28 (3), 115262, 2020 | 15 | 2020 |
| Evaluation of Synthetic Cytochrome P450-Mimetic Metalloporphyrins To Facilitate “Biomimetic” Biotransformation of a Series of mGlu5 Allosteric Ligands CC Presley, CK Perry, ES Childress, MJ Mulder, VB Luscombe, ... ACS omega 4 (7), 12782-12789, 2019 | 2 | 2019 |
| Correction to An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse … CE Canal, DE Felsing, Y Liu, W Zhu, JAT Wood, CK Perry, R Vemula, ... ACS chemical neuroscience 6 (8), 1486-1486, 2015 | 2 | 2015 |
| Abstract LB029: Comprehensive structure-function evaluation of the SHOC2 holophosphatase reveals disease mechanisms and therapeutic opportunities J Kwon, B Hajian, Y Bian, A Amor, J Fuller, C Fraley, L Baker, J So, ... Cancer Research 82 (12_Supplement), LB029-LB029, 2022 | | 2022 |
| Total synthesis of violaceimides A–E and consideration of the reported stereochemistry CK Perry, MG Fulton, CW Lindsley Tetrahedron letters 60 (40), 151103, 2019 | | 2019 |
| Total synthesis of Punicagranine CK Perry, CW Lindsley Tetrahedron letters 60 (35), 150989, 2019 | | 2019 |
| Drug Design of 5-Substituted-2-Aminotetralins Targeting the Serotonin 5-HT7 Receptor CK Perry Northeastern University, 2018 | | 2018 |
Clinton E. CanalMercer University, Department of Pharmaceutical SciencesVerified email at mercer.edu
